Ischemia induced peroxynitrite dependent modifications of cardiomyocyte MLC1 increases its degradation by MMP-2 leading to contractile dysfunction
about
Subthreshold nitric oxide synthase inhibition improves synergistic effects of subthreshold MMP-2/MLCK-mediated cardiomyocyte protection from hypoxic injuryInhibition of MMP-2 expression with siRNA increases baseline cardiomyocyte contractility and protects against simulated ischemic reperfusion injuryIschemia/reperfusion-induced myosin light chain 1 phosphorylation increases its degradation by matrix metalloproteinase 2.Emerging importance of oxidative stress in regulating striated muscle elasticity.Intracellular regulation of matrix metalloproteinase-2 activity: new strategies in treatment and protection of heart subjected to oxidative stressS-nitrosylation of TRIM72 at cysteine 144 is critical for protection against oxidation-induced protein degradation and cell death.Oxidative stress and sarcomeric proteins.Signaling by S-nitrosylation in the heart.Role of Peroxynitrite-Induced Activation of Poly(ADP-Ribose) Polymerase (PARP) in Circulatory Shock and Related Pathological Conditions.A change of heart: oxidative stress in governing muscle function?Synergistic protection of MLC 1 against cardiac ischemia/reperfusion-induced degradation: a novel therapeutic concept for the future.Low Frequency Electromagnetic Field Conditioning Protects against I/R Injury and Contractile Dysfunction in the Isolated Rat Heart.Combined subthreshold dose inhibition of myosin light chain phosphorylation and MMP-2 activity provides cardioprotection from ischaemic/reperfusion injury in isolated rat heart.SMYD2 glutathionylation contributes to degradation of sarcomeric proteins
P2860
Q28468522-8A689148-C4EC-4D84-9D47-AA2B6D5901BEQ34039481-76802A3F-FDD4-4079-A518-D2EB8C1D413EQ34260616-5D92E2B8-BF2D-4587-99F6-FE18BE1B045DQ35155257-1BDD2F95-C9C3-465A-AD01-CE2497882002Q37456901-17E1E1D1-2C7D-44FA-8B84-BF6FFC67971CQ37637150-9A5951B1-805C-453A-A010-30C5573EBA8CQ38074945-8AC6CB3C-54F1-4FB0-B5CF-E3B2ECFC79FDQ38179749-20106584-6201-4EA9-849D-136D13049ABBQ39042927-E565B8A6-823D-4406-80ED-0D5FDC48FAEEQ39310989-65F7BB76-CA55-49F3-8DB6-B1AE2521F959Q39451153-F867FA85-9328-4E26-828E-CB71E3608993Q40076268-084C946C-169F-4505-8FF6-894D1BB074A8Q42058629-6CCABC68-E870-428A-AF41-A1FB5880A705Q58600320-889DDFC1-9A95-48DC-8CBF-8050848679D8
P2860
Ischemia induced peroxynitrite dependent modifications of cardiomyocyte MLC1 increases its degradation by MMP-2 leading to contractile dysfunction
description
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2011
@ast
im Mai 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2011/05/01)
@sk
vědecký článek publikovaný v roce 2011
@cs
wetenschappelijk artikel (gepubliceerd op 2011/05/01)
@nl
наукова стаття, опублікована в травні 2011
@uk
مقالة علمية (نشرت في مايو 2011)
@ar
name
Ischemia induced peroxynitrite ...... ing to contractile dysfunction
@ast
Ischemia induced peroxynitrite ...... ing to contractile dysfunction
@en
Ischemia induced peroxynitrite ...... ing to contractile dysfunction
@nl
type
label
Ischemia induced peroxynitrite ...... ing to contractile dysfunction
@ast
Ischemia induced peroxynitrite ...... ing to contractile dysfunction
@en
Ischemia induced peroxynitrite ...... ing to contractile dysfunction
@nl
prefLabel
Ischemia induced peroxynitrite ...... ing to contractile dysfunction
@ast
Ischemia induced peroxynitrite ...... ing to contractile dysfunction
@en
Ischemia induced peroxynitrite ...... ing to contractile dysfunction
@nl
P2093
P2860
P1476
Ischemia induced peroxynitrite ...... ing to contractile dysfunction
@en
P2093
Adrian Doroszko
Beth E. Hunter
Danuta Szczesna-Cordary
Dorota Polewicz
Grzegorz Sawicki
Jolanta Sawicka
Peter E. Light
Virgilio J. J. Cadete
P2860
P304
P356
10.1111/J.1582-4934.2010.01094.X
P577
2011-05-01T00:00:00Z